StoneX Group's Q3 2026 results showed significant revenue declines in physical contracts (~39%), OTC derivatives (~15%), and listed derivatives (~11%), reflecting a return to normal after prior event-driven peaks. Despite these pullbacks, the company shows structural positives such as a 7% sequential increase in client balances and growing fee income. However, these factors are not yet strong enough to justify a Buy rating. The stock remains a Hold as investors await clearer signs of cost synergies, Prime Services progress, and sustained book value growth before considering an upgrade.
RLX Technology reported Q2 2026 earnings per share of $0.03 and revenue of $148.87 million, missing analyst expectations. Despite this, the company achieved 14.8% year-over-year revenue growth, mainly due to its expanding international market, which ...
RBC Capital set a new price target of $9.00 for Paysafe, indicating a potential 34.45% upside from its current price of $6.69. Paysafe reported 7% revenue growth in the first half of 2026, driven by strategic investments in marketing and technology, ...
Greenland Technologies (GTEC) reported strong Q2 2026 results, with earnings per share of $0.13 surpassing estimates of $0.09 and revenue rising 37.6% to $29.9 million. The company turned profitable with a net income of $4.9 million, reversing last y...
NRx Pharmaceuticals is set to report quarterly earnings with an expected loss of $0.09 per share and revenue of $1.33 million, reflecting ongoing financial challenges. Despite negative profitability and cash flow metrics, the company received positiv...
Applied Materials reported strong Q3 financial results with revenue up 25% to $9.12 billion and adjusted EPS rising 41% to $3.50, beating Wall Street estimates. However, the stock fell over 5% after earnings due to market expectations being even high...
